1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with HIV: Part I. Prevention of exposure

American Family Physician

Volumn 56, Issue 3, 1997, Pages 823-830

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CANDIDIASIS; CHICKENPOX; CHILD; COCCIDIOIDOMYCOSIS; CRYPTOCOCCOSIS; CRYPTOSPORIDIOSIS; CYTOMEGALOVIRUS INFECTION; HERPES SIMPLEX; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MICROSPORIDIOSIS; MYCOBACTERIOSIS; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; REVIEW; TOXOPLASMOSIS; TRAVELLER DIARRHEA; TUBERCULOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; HIV INFECTIONS; HUMANS; UNITED STATES;

EID: 0030880948     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. USPHS/IDSA Prevention of Opportunistic Infections Working Group. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. MMWR 1995;44(No. RR-8).
2. USPHS/IDSA Prevention of Opportunistic Infections Working Group. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease specific recommendations. Clin Infect Dis 1995;21(Suppl 1):S32-S43.
3. USPHS/IDSA Prevention of Opportunistic Infections Working Group. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. Ann Intern Med 1996;124:348-68.
4. Kaplan JE, Masur H, Jaffe HW, Holmes KK. Reducing the impact of opportunistic infections in patients with HIV infection: new guidelines. JAMA 1995;274:347-8.
5. Gross PA, Barrett TL, Dellinger EP, Krause PJ, Martone WJ, McGowan JE Jr, et al. Purpose of quality standards for infectious diseases. Clin Infect Dis 1994;18:421.
6. Kaplan JE, Masur H, Holmes KK, McNeil MM, Schonberger LB, Navin TR, et al. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. Clin Infect Dis 1995;21(Suppl 1):S1-11.
7. Selik RM, Chu SY, Ward JW. Trends in infectious diseases and cancers among persons dying of HIV infection in the United States from 1987 to 1992. Ann Intern Med 1995;123:933-6.
8. Moore RD, Chaisson RE. Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med 1996;124:633-42.
9. Jones JL, Hanson DL, Ward JW, Kaplan JE. Incidence trends in AIDS-related opportunistic illnesses in injecting drug users and men who have sex with men [Abstract We.C.3418] Vol 2. XI International Conference on AIDS. Vancouver, July 7-12, 1996.
10. Karon JM, Rosenberg PS, McQuillan G, Khare M, Gwinn M, Petersen LR. Prevalence of HIV infection in the United States, 1984 to 1992. JAMA 1996;276:126-31.
11. Kaplan JE, Masur H, Holmes KK, Wilfurt CM, Sperling R, Baker SA, et al. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: an overview. Clin Infect Dis 1995;21(Suppl 1):S12-31.
12. El-Sadr W, Oleske JM, Agins BD, et al. Evaluation and management of early HIV infection. Clinical practice guideline no. 7. Rockville, Md.: U.S. Dept. of Health and Human Services, Public Health Service, 1994; AHCPR publication no. 94-0572.
13. Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, et al. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society -USA Panel. JAMA 1997;277:1962-9.